BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29565452)

  • 1. Differential expression patterns of the short and long isoform of cFLIP on FasL‑mediated apoptosis.
    Um HJ; Chauhan AK; Min KJ; Kwon TK
    Oncol Rep; 2018 May; 39(5):2443-2449. PubMed ID: 29565452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression.
    Han MA; Woo SM; Min KJ; Kim S; Park JW; Kim DE; Kim SH; Choi YH; Kwon TK
    Chem Biol Interact; 2015 Feb; 228():69-78. PubMed ID: 25619640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP.
    Seo BR; Min KJ; Woo SM; Choe M; Choi KS; Lee YK; Yoon G; Kwon TK
    Antioxid Redox Signal; 2017 Aug; 27(4):215-233. PubMed ID: 27927016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo.
    Ram DR; Ilyukha V; Volkova T; Buzdin A; Tai A; Smirnova I; Poltorak A
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1606-11. PubMed ID: 26798068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycin A sensitizes cells to TRAIL-induced apoptosis through upregulation of DR5 and downregulation of c-FLIP and Bcl-2.
    Lee SJ; Kim EA; Song KS; Kim MJ; Lee DH; Kwon TK; Lee TJ
    Int J Oncol; 2012 Oct; 41(4):1425-30. PubMed ID: 22842544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP down-regulates cFLIP(L) expression by promoting ubiquitin/proteasome-mediated cFLIP(L) degradation.
    Noh HJ; Lee SJ; Sung EG; Song IH; Kim JY; Woo CH; Kwon TK; Lee TJ
    J Cell Biochem; 2012 Dec; 113(12):3692-700. PubMed ID: 22753273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
    Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
    Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.
    Ivanov VN; Hei TK
    Exp Cell Res; 2006 Dec; 312(20):4120-38. PubMed ID: 17070520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
    Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gambogic acid induces apoptosis and sensitizes TRAIL-mediated apoptosis through downregulation of cFLIPL in renal carcinoma Caki cells.
    Jang JH; Kim JY; Sung EG; Kim EA; Lee TJ
    Int J Oncol; 2016 Jan; 48(1):376-84. PubMed ID: 26648023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling.
    Du J; Wu J; Fu X; Tse AK; Li T; Su T; Yu ZL
    Oncotarget; 2016 Aug; 7(32):52218-52229. PubMed ID: 27418138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑218 promotes apoptosis of SW1417 human colon cancer cells by targeting c‑FLIP.
    Meng Q; Chen Y; Lian B; Shang Y; Yang H
    Oncol Rep; 2018 Aug; 40(2):916-922. PubMed ID: 29845219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osthole enhances TRAIL-mediated apoptosis through downregulation of c-FLIP expression in renal carcinoma Caki cells.
    Min KJ; Han MA; Kim S; Park JW; Kwon TK
    Oncol Rep; 2017 Apr; 37(4):2348-2354. PubMed ID: 28350076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIP (L).
    Jang JH; Cho YC; Kim KH; Lee KS; Lee J; Kim DE; Park JS; Jang BC; Kim S; Kwon TK; Park JW
    Int J Oncol; 2014 Oct; 45(4):1680-90. PubMed ID: 24993441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators.
    García-García C; Fumarola C; Navaratnam N; Carling D; López-Rivas A
    Biochem Pharmacol; 2010 Mar; 79(6):853-63. PubMed ID: 19896469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR
    Jang JH; Park CY; Sung EG; Song IH; Kim JY; Jung C; Sohn HY; Lee TJ
    Genes Genomics; 2021 Oct; 43(10):1199-1207. PubMed ID: 34302634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.